Unless otherwise noted all seminars are at 11:00 am in 1022 Life Sciences (LSA).

 

MCB/ECH 294 Seminar
2009 Fall Schedule

2008 --> 

September 25, 2009 Organizational Meeting
October 2, 2009

Introduction to the Little Bang/Big Bang Business Competition
Nicole Starsinic
Associate Director
Presentation
Center for Entrepreneurship, UC Davis, CA

October 9 , 2009

New Advances in Cancer Therapeutics
Paul Hastings
President & CEO
John Lewicki
OncoMed Pharmaceuticals, Inc., Redwood City, CA

October 16, 2009

 

Predicting Patient Response to Cancer Chemotherapy
Paul T. Henderson, PhD
Founder, Accelerated Medical Diagnostics LLC
Assistant Professor
Division of Hematology & Oncology, Dept. Internal Medicine, UC Davis Medical Center

October 23, 2009

 

Automated Solutions for Life Sciences and Diagnostics
Paul Richardson, PhD
Vice President, Research and Development
Progentech USA, Inc., Emeryville, CA

October 30, 2009

 

PARP Inhibitors in Cancer Therapy
Hoyoung Huh, MD, PhD
President & CEO
BiPar Sciences, Inc., Brisbane, CA

November 6, 2009

Getting a Drug Into Clinical Trials: A Case Study in the Translation of a Novel Epilepsy Drug
Michael Rogawski, MD, PhD
Professor & Chair
Dept. of Neurology, School of Medicine, UC Davis, CA

November 13, 2009

 

Engineering and Development of XOMA 052, a Novel anti-IL-1b Antibody
Steve Doberstein, PhD
Vice President, Research
Xoma, Berkeley, CA

November 20, 2009

 

In vitro Selection: Creating New Tools for Molecular Biology
Jennifer Ong, PhD
Staff Scientist
New England Biolabs, Ipswich, MA
November 27, 2009 Thanksgiving Holiday
December 5, 2009 The Magnitude and Phase of Genentech Biomedical Imaging
Joan Greve, PhD
Director, Biomedical Imaging
Genentech, San Francisco, CA

Reminder: Sponsorship of seminars includes the UCD Biotechnology Program, NIH Training Grant in Biomolecular Technology, the UCD College of Biological Sciences, UCD College of Engineering and NSF CREATE-IGERT Training Grant.

 

 

 

MCB/ECH 294 Seminar
2009 Spring Schedule

2008 --> 

Unless otherwise noted all seminars are at 11:00 am in 1022 Life Sciences (LSA).

April 3, 2009 Organizational Meeting
April 10 , 2009

Protein Mass Spectrometry in a Biotech Protein Production Pipeline
Roger Mercer, PhD
Senior Scientist
Exelixis, Inc., San Diego, CA

April 17 , 2009

Genomics Platform For Natural Products Development
Magalie Guilhabert, PhD
Microbiology and Molecular Biology Scientist
AgraQuest, Inc., Davis, CA

April 24, 2009

 

What Is the Mouse Trying To Tell Us? The Post Genomic World and One Medicine
Robert D. Cardiff, M.D., PhD
Director
Center for Genomic Pathology, UC Davis

May 1 , 2009

 

The Application of Synthetic Genomics to Renewable Fuels and Chemicals
Paul Roessler, PhD
Vice President
Renewable Fuels and Chemicals
Synthetics Genomics, Inc., La Jolla, CA

May 8 , 2009

 

BIO-cycling Down the Entrepreneurial Path Amplimmune - A Paradigm Shift in Translational Development
Michael Richman, MSBA
President & CEO
Presentation
Amplimmune, Inc., Rockville, MD

May 15 , 2009

Molecular Diagnostic Opportunities in Veterinary and Human Medicine
Christian Leutenegger, Dr. Vet. Med., PhD, FVH
Regional Head of Molecular Diagnostics (MDx)
IDEXX Reference Laboratories, West Sacramento, CA

May 22 , 2009

 

Lessons Learned As A Serial Tech Entrepreneur
Gary Hooper
President & CEO
VerdiChrys Technologies, Inc.

May 29 , 2009

 

The Promise of Small Interfering RNA As A Human Therapeutic
Mike Flanagan, PhD
Senior Director, RNA Sciences
Merck Research Laboratories, San Francisco, CA

Reminder: Sponsorship of seminars includes the UCD Biotechnology Program, NIH Training Grant in Biomolecular Technology, the UCD College of Biological Sciences, UCD College of Engineering and NSF CREATE-IGERT Training Grant.

 

 

MCB/ECH 294 Seminar
2009 Winter Schedule

2008 --> 

January 9, 2009 Organizational Meeting
January 16, 2009

Regulatory Politics of Biotechnology: Diplomacy or Defense?
Roger Clemens, DrPH, CNS, FACN, FIFT
Assoc. Director of Regulatory Science Program at USC School of Pharmacy
Consulting Advisory for ETHorn
ETHorn, La Mirada, CA
Presentation
ETHorn Profile     

January 23, 2009

Transgenic Plants for Food Security
Martina Newell-McGloughlin, DSc
Director, UC Systemwide Biotech Research & Education Program (BREP)
UC BREP, Davis, CA
Presentation
UC BREP

January 30, 2009

 

Public Intellectual Property Resource for Agricultural Biotechnology
Alan Bennett, PhD
Executive Director of PIPRA (Public Intellectual Property Resource for Agriculture)
UC Davis
Presentation
PIPRA Profile

February 6, 2009

 

Genetics Gets Personal: How to Read Your Genome and What It Means for Your Health
Brian Naughton, PhD
Founding R & D Architect
23 and Me, Inc., Mountain View, CA
Presentation
23 and Me, Inc.

February 13, 2009

 

Human Embryonic Stem Cells: Advancing Technology for Therapeutic Application
Jane Lebkowski, PhD
Senior Vice President of Regenerative Medicine
Geron, Menlo Park, CA
Geron
February 20, 2009

A Novel Source for Biofuels
Lissa Morgenthaler-Jones
CEO and President
LiveFuels, Inc. San Carlos, CA
LiveFuels, Inc.

February 27, 2009

Examining RBC Regulation of BP in Small Vessels
William Ristenpart, PhD
Assistant Professor
Dept. of Chem Engin & Material Science & Dept. of Food Science & Tech, UC Davis
UC Davis Food Science, Profile

March 6, 2009

230 Wellman Hall!!

PARC: Pharmacogenomics and Risk of Carciovascular Disease
Marisa Wong Medina, PhD
Assistant Staff Scientist
CHORI (Children's Hospital Oakland Research Institute), Oakland, CA
CHORI

March 13, 2009

 

Acquisition of Lipomics and the Combined Company Strengths
Eddie Moler, PhD
Associate Director of Biostatistics and Informatics
Tethys Biosciences, Inc., Emeryville, CA
Tethys Biosciences, Inc.

Reminder: Sponsorship of seminars includes the UCD Biotechnology Program, NIH Training Grant in Biomolecular Technology, the UCD College of Biological Sciences, UCD College of Engineering and NSF CREATE-IGERT Training Grant.

 

 

 

Copyright © 2009 by UC Davis